For laboratory research use only. Not for human or veterinary use.

Same-day dispatch on orders before 4 PM ET · Support

Multi-Peptide Blends: What the COA Should Show for Each Component

A certificate of analysis (COA) for a peptide blend should report results for each component separately. That means each peptide’s measured mass by LC-MS, its amount per vial against the label claim, its own HPLC purity and impurity profile, and chromatographic evidence that the components were resolved and correctly assigned.

What to check for each component

AttributeWhat the COA should showTypical technique
IdentityObserved mass for each peptide next to its theoretical massLC-MS (ESI)
Amount per vial (assay)Measured mg of each peptide against its label claim, with units statedRP-HPLC against a reference standard for each peptide
PurityA separate area-% purity for each peptide, not one figure for the vialRP-HPLC / UHPLC with UV detection
Resolution and peak assignmentChromatogram showing the components separated, with each main peak identifiedHPLC with MS confirmation of each peak
Related impuritiesImpurities reported against the parent peptide they belong toHPLC; LC-MS for identification
Counter-ion and net peptide contentWhether stated amounts are salt weight or net peptide, and how counter-ion was measuredIon chromatography, HPLC-ELSD, 19F NMR (for TFA); amino acid analysis
Lot and method informationLot number, test date, and the method or reference standard used for each componentDocumentation

What a lyophilized multi-peptide blend is

A multi-peptide blend is a single vial in which two or more peptides are co-filled and freeze-dried together. The label states the amount of each component, for example “5 / 5 mg” for a two-peptide blend. Because one vial carries several analytes, every analytical question that applies to a single peptide (identity, quantity, purity, impurities, salt form) has to be answered once for each component. The validation principle of specificity in ICH Q2(R2) applies directly: a procedure must be shown to measure the intended analyte in the presence of other components that may be present, and in a blend those include the co-filled peptides and their impurities [1].

Why one overall purity number is not enough

An HPLC purity value is an area percentage: the main peak area divided by the total integrated area. In a blend there are two or more intended peaks, so a single figure for the whole vial can hide a low-purity component behind a high-purity one, and it says nothing about whether each peptide is present in the stated ratio. Specifications for peptide and protein materials are built around attributes of the defined molecule, including identity, purity and impurities, and quantity [2]. For a blend, those attributes belong to each peptide, so they should be reported for each peptide.

Per-component identity by LC-MS

Mass spectrometry confirms that the expected sequence is present by matching the observed mass to the theoretical mass. For a blend, the COA should list a theoretical and an observed mass for every component. A spectrum that shows only one expected mass, or a single “MS: conforms” line without values, does not establish that every labelled peptide is in the vial. Reviews of peptide impurities note that pharmacopoeial methods have relied mainly on HPLC-UV with identification by retention time, and argue that MS detection adds needed specificity [3].

Per-component assay against the label claim

Assay answers how much of each peptide is in the vial. The usual approach is reversed-phase HPLC with each peptide quantified against its own reference standard, so the result can be compared with that component’s label claim. A total mass for the vial cannot show whether the ratio is correct. Amino acid analysis is a recognized quantitation tool for peptides [5], but applied to a whole blend it returns pooled amino acids from all components, so on its own it may not apportion content between peptides that share residues.

Chromatographic resolution and peak assignment

Per-component results are only meaningful if the components are separated. If two peptides, or a peptide and another component’s impurity, co-elute, the integrated areas are wrong for both. USP <621> defines resolution and system suitability parameters used to show that a chromatographic system separates the peaks of interest adequately [4]. On a blend COA, look for a chromatogram with clearly separated main peaks, a stated retention time for each, and confirmation by MS that each peak is the peptide it is labelled as.

How impurity profiles should be reported

Synthetic peptides carry related impurities such as deletion and insertion sequences, oxidized and deamidated forms, diastereomers, and residual protecting-group adducts, many of which are distinguished by characteristic mass shifts [3]. FDA guidance on certain synthetic peptides recommends identifying peptide-related impurities at 0.10% and above and encourages sensitive, high-resolution procedures such as UHPLC with high-resolution MS [6]. That guidance addresses drug applications, not research reagents, but it shows the level of detail regulators expect. For a blend, each impurity should be attributed to the parent peptide it derives from and expressed relative to that component.

Counter-ions and net peptide content for each component

Peptides from solid-phase synthesis are commonly isolated as trifluoroacetate (TFA) salts. A 2025 study measured TFA at up to roughly a third of the salt weight in purified peptides and recommended that counter-ion content be quantified and reported [7]. USP lists dedicated procedures for acetic acid and TFA in peptides [5]. In a blend, ask whether “5 mg” means 5 mg of peptide salt or 5 mg of net peptide for each component, and how counter-ion and water were assigned when they are measured for the vial as a whole. USP <1503> covers quality attributes of synthetic peptide drug substances and is a useful reference for these terms [8].

Stability considerations specific to blends

Components in one vial can degrade by different routes. Methionine is among the residues most susceptible to oxidation, and asparagine deamidation is fastest in Asn-Gly and Asn-Ser sequences [9]. Transition metal ions are a recognized factor in oxidative degradation [9], so when one component is a copper complex such as GHK-Cu, oxidation-related impurities of the other components deserve attention in stability data. Whether a specific combination interacts should be shown by data, not assumed either way. Stability results for a blend should track purity and impurities for each component over time.

Questions to ask a supplier

  • Does the COA report purity, assay and observed mass for each component separately?
  • Was each component quantified against its own reference standard?
  • Can you provide the chromatogram showing that all components are resolved, with MS confirmation of each peak?
  • Are impurities attributed to a parent peptide and reported relative to that component?
  • Are label amounts stated as peptide salt or net peptide, and what is the counter-ion?
  • Is there per-component stability data for the blend as filled?

Red flags on a blend COA

  • One purity percentage for the whole blend.
  • No theoretical and observed mass for each component.
  • A total mg value for the vial with no per-component amounts.
  • No chromatogram, or a chromatogram with unlabelled or overlapping main peaks.
  • No lot number, test date or method reference.

Kalibra’s research blends are listed under Research Blends, including CJC-1295 (no DAC) + Ipamorelin, BPC-157 + TB-500 and BPC-157 + GHK-Cu + TB-500. For any blend, check that the certificate reports each component separately. For single-peptide certificates, see How to Read a Peptide Certificate of Analysis, and for storage practice, see Storing and Handling Lyophilized Peptides.

Frequently asked questions

Is a single purity value acceptable for a peptide blend?

Not on its own. A single area-% figure can hide a low-purity component and does not show the component ratio. Each peptide should have its own purity and assay result [2].

Why should the COA list a mass for every component?

An observed mass matching the theoretical mass is the identity evidence for each peptide. Without a mass for every component, the COA does not confirm that each labelled peptide is present [3].

What does co-elution mean for blend results?

If peaks overlap, their areas cannot be assigned correctly, so purity and assay for the affected components are unreliable. Look for resolved peaks with MS confirmation of each [4].

Does “5 / 5 mg” mean 5 mg of pure peptide each?

Not necessarily. The figure may be peptide salt weight, which includes counter-ion and water. Ask whether amounts are net peptide and how counter-ion was measured [7].

References

  1. ICH. Q2(R2) Validation of Analytical Procedures. EMA page
  2. ICH. Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products. 1999. PDF
  3. D’Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 2014. PMID 25044089
  4. USP. Notice of Adoption of Harmonized Standard: <621> Chromatography. USP notice
  5. USP. Standards for Peptides (<1052> Amino Acid Analysis, <503> Acetic Acid in Peptides, <503.1> Trifluoroacetic Acid in Peptides). PDF
  6. US FDA. ANDAs for Certain Highly Purified Synthetic Peptide Drug Products That Refer to Listed Drugs of rDNA Origin. Guidance for Industry, May 2021. FDA page
  7. Erckes V, Streuli A, Chamera Rendueles L, Krämer SD, Steuer C. Towards a Consensus for the Analysis and Exchange of TFA as a Counterion in Synthetic Peptides and Its Influence on Membrane Permeation. Pharmaceuticals. 2025;18(8):1163. Article
  8. USP. <1503> Quality Attributes of Synthetic Peptide Drug Substances. USP-NF
  9. Akbarian M, Chen SH. Instability Challenges and Stabilization Strategies of Pharmaceutical Proteins. Pharmaceutics. 2022;14(11):2533. PMC

For Research Use Only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. This guide is general laboratory reference information.

0
Your Cart
Empty CartYour cart is emptyReturn to Shop
Scroll to Top